The purified soluble recombinant CCR5-T4L protein showed significant antiviral potency in inhibiting R5 tropic HIV-1 virus infection only at higher concentrations in the THP1 cell line but enhanced viral infection at lower concentrations. Here, CCR5 is linked to viral infectious disease.